Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929859 · ClinicalTrials.gov registry record · Phase 1
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
A Phase 1 study of Speech Sound Disorder, sponsored by Syracuse University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT05929859: Recruiting Phase 1 study of Speech Sound Disorder, sponsored by Syracuse University.
NCT05929859 is a Phase 1 study of Speech Sound Disorder that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 84 participants, roughly in line with the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05929859, a Phase 1 study of Speech Sound Disorder, is actively recruiting participants, sponsored by Syracuse University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized-controlled trial is to compare distributed treatment schedules and intensive treatment schedules in 84 school-age children with residual speech sound disorders. The main question it aims to answer is: * How does intensive and distributed treatment affect speech sound learning in residual speech sound disorder? Some participants will be treated with a traditional Distributed schedule of 2 sessions per weeks for 8 weeks (16 hours total), whereas others will be treated with an Intensive schedule and will complete 16 hours of treatment in 4 weeks.
Primary Outcome
To assess generalization of treatment gains to untreated words, participants will read a 200-word probe list eliciting the treated sound (/ɹ/ or /s/). Stimuli in each probe will be presented individually in randomized order. No auditory models will be provided; for children with reading difficulty, semantic cues will be provided to elicit the intended word. Individual words will be isolated from the audio record of each word probe and presented in randomized order for binary rating (correct/inco
Conditions Studied
Interventions
- BEHAVIORAL Speech Motor Chaining
Study Locations (1)
New York
- Syracuse University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2023-10-26 |
| Est. Completion | 2028-02-29 |
| Phase | Phase 1 |
What NCT05929859 shows while recruiting
NCT05929859 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, roughly in line with the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target.
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 1 intervention - of which Speech Motor Chaining is the first listed.
NCT05929859 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05929859 about?
NCT05929859 is a clinical study titled "Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders". The goal of this randomized-controlled trial is to compare distributed treatment schedules and intensive treatment schedules in 84 school-age children with residual speech sound disorders. The main question it aims to answer is: * How does intensive and distributed treatment affect speech sound lea...
What is the current status of trial NCT05929859?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2023-10-26. Estimated completion is 2028-02-29.
What conditions does trial NCT05929859 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT05929859?
The interventions under investigation include: Speech Motor Chaining (BEHAVIORAL).
Who is sponsoring clinical trial NCT05929859?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929859 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05929859's enrollment target sits among peer trials
84 5th of 15 higher than 11 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment Targets in Spanish and English Bilingual Speech Intervention
RECRUITING · Phase 1
-
Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
RECRUITING
-
Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial
RECRUITING · Phase 2
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Generalization With AI Navigation Using StaRt
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI